“Since I’ve been vice president, we have capped the cost of prescription medication for seniors at $2,000 a year.” The development of green inhalers jeopardizes those gains. Drug companies will be ...
The news followed an investigation by POLITICO’s E&E News into climate-friendly inhalers and how drug giants are developing them to undermine competition. The pharmaceutical giant AstraZeneca has ...
Many current inhalers for conditions such as asthma contain propellants that are potent greenhouse gases. A study from researchers at the University of Cambridge has found that switching to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback